Circulating microparticles: challenges and perspectives of flow cytometric assessment.

  title={Circulating microparticles: challenges and perspectives of flow cytometric assessment.},
  author={Eduard Shantsila and Silvia Montoro-Garc{\'i}a and Pilar Gallego and Gregory Yoke Hong Lip},
  journal={Thrombosis and haemostasis},
  volume={111 6},
Circulating blood microparticles are likely to play a significant role as messengers of biological information. Their accurate quantification and characterisation is challenging and needs to be carefully designed with preferable usage of fresh minimally-processed blood samples. Utilisation of flow cytometers specifically designed for analysis of small-size particles is likely to provide considerable methodological advantages and should be the preferable option. This viewpoint manuscript… 

Figures from this paper

Cutting-Edge Analysis of Extracellular Microparticles using ImageStreamX Imaging Flow Cytometry

It is proposed that the ImageStreamX could be used effectively to advance this scientific field, and simultaneous phenotypic definition of the parent cells and offspring microparticles along with real time microparticle generation kinetics is proposed.

Microparticles as biomarkers of venous thromboembolic events.

The potential role of plasma MPs as biomarkers in detecting acute unprovoked VTE, predicting VTE occurrence in high-risk situations (mainly cancer), and ultimately, currently available studies on the prognostic role of MPs to guide primary and secondary VTE prevention protocols are discussed.

The Biosensing of Microparticles : Benefits and Perspectives

This editorial comment focuses on the current knowledge about MPs and analytical methods of its detection and contemporary approaches regarding novel techniques of microparticle determination, measurements and assay.

Microparticle analysis in disorders of hemostasis and thrombosis

  • M. MooberryN. Key
  • Biology
    Cytometry. Part A : the journal of the International Society for Analytical Cytology
  • 2016
Flow cytometry (FCM) remains the most frequently utilized strategy for MP detection; however, it is associated with significant technological limitations, and preanalytical and analytical variables can influence the detection of MPs by FCM, rendering data interpretation difficult.

Clinical significance of procoagulant microparticles

It is suggested that MPs may be a useful biomarker to identify thrombosis, which is currently increasing in the number and type of clinical disorders associated with elevated MPs.

Measurement of microvesicle levels in human blood using flow cytometry

  • W. Chandler
  • Biology
    Cytometry. Part B, Clinical cytometry
  • 2016
The goal of this review is to aid investigators in applying current best practices to microvesicle measurements to help expand use of flow cytometry as a clinical and research tool.

Microparticles as biomarkers of lung disease: enumeration in biological fluids using lipid bilayer microspheres.

An enhanced FCM MP gating and enumeration technique based on the use of novel engineered lipid bilayer microspheres (LBMs) is reported, finding LBMs to be superior to commercial bead preparations, showing the smallest fixed bias and limits of agreement in Bland Altman analyses.



Impact of pre‐analytical parameters on the measurement of circulating microparticles: towards standardization of protocol

Microparticles received an increasing interest both as biomarkers and biovectors in coagulation, inflammation and cancer, and among the limitation of such studies, pre‐analytical steps remains an important source of variability and artifacts in MP analysis.

Measurement of platelet microparticles.

Methodology for light scatter-based flow cytometry as well as impedance-basedflow cytometry for the enumeration and characterization of platelet microparticles are described.

An innovative flow cytometric approach for small-size platelet microparticles: influence of calcium.

A sensitive protocol for the analysis of circulating and in vitro induced small-size PMPs is presented and it is indicated that prolonged storage and thrombin induce the release of AnV+ MPs whereas PS exposure in pre-existent MPs is not affected byThrombin.

Flow cytometric measurement of microparticles: Pitfalls and protocol modifications

The need to standardize assay protocols in order to obtain consistent measurements of microparticle levels is illustrated, as elevated levels of platelet- and erythrocyte-derived microparticles were detected in heparin and PPACK-anticoagulated samples as compared to samples anticoagulate with ACD or sodium citrate.

Flow cytometric analysis of microparticle phenotype and their role in thrombin generation

The role of platelet, red cell, and leucocyte‐derived microparticles in the measurement of thrombin generation is investigated.

Novel test for microparticles in platelet‐rich plasma and platelet concentrates using dynamic light scattering

Dynamic light scattering (DLS) is ideally suited to measure particles of submicron size but has previously been limited to the analysis of PLT‐free samples.

Detection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing

It is believed that staining with Annexin V is necessary to distinguish true events from cell debris or precipitates, and Buffers should be filtered and fresh samples should be analyzed, or storage periods will have to be standardized, to minimize contamination by smaller size platelets.

Circulating microparticles: new insights into the biochemical basis of microparticle release and activity

Understanding the mechanism(s) governing microparticle release processes may be critical to understanding their precise role in various pathophysiological processes and thus indicate new potential routes to therapy.